Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

On December 19, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a paper entitled “The Future of U.S.-China Biotechnology Competition.” The paper ...

Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

Cathie Wood’s ARK Investment Management sharply increased its exposure to AI-driven biotechnology and cryptocurrency during ...

KKR's 2026 Outlook finds value beyond the S&P 500. Explore investment strategies in Asia, biotech, and critical infrastructure.

MAIA Biotechnology (MAIA) announced that independent directors including Adelina Louie Ngar Yee and Stan Smith, purchased common stock and ...

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if this is right time to buy.

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...